Literature DB >> 6152630

Effects of pyridoxal phosphate treatment on the (Na + K)-ATPase.

J D Robinson.   

Abstract

Reaction of a dog kidney (Na + K)-ATPase with pyridoxal phosphate, followed by borohydride reduction, reduced the catalytic activity when measured subsequently. The time course of inactivation did not follow a first-order process, and certain characteristics of the residual enzymatic activity were modified. Moreover, various catalytic activities were diminished differently: Na-ATPase activity was largely spared, K-phosphatase activity was diminished only by half that of the (Na + K)-ATPase, whereas (Na + K)-CTPase and Na-CTPase activities were diminished more. ATP, ADP, CTP, nitrophenyl phosphate, and Pi all protected against inactivation. Increasing salt concentrations increased inactivation, but KCl slowed and NaCl hastened inactivation when compared with choline chloride. Occupancy of certain substrate or cation sites seemed more crucial than selection of conformational states. For the residual (Na + K)-ATPase activity the K0.5 for K+ was lower and the K0.5 for Na+ higher, while the sensitivities to ouabain, oligomycin, and dimethylsulfoxide were diminished; for the residual K-phosphatase activity the K0.5 for K+ was unchanged, the sensitivity to ouabain and oligomycin diminished, but the stimulation by dimethylsulfoxide increased. These properties cannot be wholly accommodated by assuming merely shifts toward either of the two major enzyme conformations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6152630     DOI: 10.1007/BF00751049

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  21 in total

1.  Na+ sites of the (Na+ + K+)-dependent ATPase.

Authors:  J D Robinson
Journal:  Biochim Biophys Acta       Date:  1977-06-10

2.  Modification of the (Na+ + K+)-dependent ATPase by acetic anhydride and trinitrobenzene sulfonate: specific changes in enzymatic properties.

Authors:  J D Robinson; M S Flashner
Journal:  Arch Biochem Biophys       Date:  1979-09       Impact factor: 4.013

3.  Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. I. An associated sodium-activated transphosphorylation.

Authors:  S Fahn; G J Koval; R W Albers
Journal:  J Biol Chem       Date:  1966-04-25       Impact factor: 5.157

4.  Characterization of conformational changes in (Na,K) ATPase labeled with fluorescein at the active site.

Authors:  S J Karlish
Journal:  J Bioenerg Biomembr       Date:  1980-08       Impact factor: 2.945

5.  Binding to the high-affinity substrate site of the (Na+ + K+)-dependent ATPase.

Authors:  J D Robinson
Journal:  J Bioenerg Biomembr       Date:  1980-08       Impact factor: 2.945

Review 6.  Transport adenosine triphosphatases: properties and functions.

Authors:  F Schuurmans Stekhoven; S L Bonting
Journal:  Physiol Rev       Date:  1981-01       Impact factor: 37.312

7.  Differences between CTP and ATP as substrates for the (Na + K)-ATPase.

Authors:  J D Robinson
Journal:  Arch Biochem Biophys       Date:  1982-02       Impact factor: 4.013

8.  Sensitivity of the (Na+ + k+)-atpase to state-dependent inhibitors. Effects of digitonin and Triton X-100.

Authors:  J D Robinson
Journal:  Biochim Biophys Acta       Date:  1980-06-06

9.  A model for the reaction pathways of the K+-dependent phosphatase activity of the (Na+ + K+)-dependent ATPase.

Authors:  J D Robinson; G M Levine; L J Robinson
Journal:  Biochim Biophys Acta       Date:  1983-06-23

10.  Effects of oligomycin on the partial reactions of the sodium plus potassium-stimulated adenosine triphosphatase.

Authors:  A S Hobbs; R W Albers; J P Froehlich
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

View more
  1 in total

1.  Differential reactivity of lysine residues of the red blood cell Ca2+ pump involved in the E1-E2 conformational equilibrium.

Authors:  C Donnet; A J Caride; H N Fernández; J P Rossi
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.